Literature DB >> 3941399

Effects of nimodipine on cerebral blood flow in conscious rat.

K Kanda, S F Flaim.   

Abstract

The purpose of this study was to determine the effects of the calcium channel blocker nimodipine (NM) on cerebral blood flow in the rat under conscious and anesthesized conditions and to compare these to effects of the drug in other circulations. Regional blood flows were measured using the radioactive microsphere technique. Hemodynamic parameters were assessed at the time of blood flow determinations in conscious rats and in pentobarbital-anesthetized rats. NM was administered i.v. using a cumulative dosing regimen in conscious (6, 24 and 60 micrograms/kg) and anesthetized (6 and 60 micrograms/kg) rats. In conscious rats, NM dose-dependently increased coronary blood flow whereas significantly lowering pressure-rate product and slightly but significantly reduced mean arterial pressure and systemic vascular resistance. In conscious rats, NM had no significant effect on cerebral blood flow or cerebral vascular resistance. In anesthetized rats, cerebral and systemic vascular resistances were higher compared to conscious animals. In anesthetized animals, NM reduced mean arterial pressure and systemic resistance to a greater extent than in conscious rats and significantly increased cerebral blood flow. Base-line coronary resistance was similar in conscious and anesthetized rats and the coronary dilator effects of NM were also similar under the two conditions. These findings suggest that NM is not a selective cerebral vasodilator in rats and that the cerebral dilator effects of this drug are not apparent in conscious rats. Only under the high cerebral resistance condition induced by pentobarbital anesthesia was NM found to be a cerebral vasodilator in the rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941399

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  The role of calcium antagonists in the treatment of cerebrovascular disease.

Authors:  J J Murphy
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

2.  Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.

Authors:  S M Gardiner; A M Compton; T Bennett; P A Kemp; U Ney
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

3.  A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors.

Authors:  G H Bone; E Majchrowicz; P R Martin; M Linnoila; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 5.  Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

6.  Nimodipine has no effect on the cerebral circulation in conscious pigs, despite an increase in cardiac output.

Authors:  W J van der Giessen; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.